vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT
· Real-Time Price · USD
15.46
1.43 (10.19%)
At close: Aug 15, 2025, 3:58 PM
15.73
1.75%
After-hours: Aug 15, 2025, 04:10 PM EDT
vTv Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -23.87M | -22.9M | -21.55M | -20.59M | -23.29M | -24.09M | -25M | -27.61M | -24.54M | -21.42M | -25.07M | -28.47M | -24.46M | -21.21M | -17.73M | -6.64M | -7.43M | -11.58M |
Depreciation & Amortization | 56K | 76K | 89K | 90K | 90K | 90K | 90K | 90K | 92K | 91K | 92K | 91K | 89K | 89K | 89K | 89K | 90K | 90K |
Stock-Based Compensation | 3.42M | 3.35M | 2.76M | 2.33M | 1.92M | 1.46M | 1.58M | 1.47M | 1.37M | 1.14M | 1.27M | 1.98M | 2.11M | 2.4M | 2.36M | 1.63M | 1.33M | 1.06M |
Other Working Capital | 1.48M | -208K | -246K | 656K | -1.04M | 1.16M | -502K | -398.14K | -3.37M | -865.14K | 1.07M | 230K | 2.3M | -534K | -2.25M | -2.25M | -3.5M | -4.41M |
Other Non-Cash Items | -843K | -2.39M | -2.38M | -2.39M | 1.07M | 4.41M | 3.54M | 4.51M | 994K | -2.09M | 2.3M | 7.28M | 6.88M | 2.75M | -43.77K | -4.7M | -3.92M | 280K |
Deferred Income Tax | n/a | n/a | n/a | 108K | 108K | -3.68M | -3.68M | -3.79M | -3.79M | n/a | n/a | -6.33M | -5.95M | -5.71M | -4.01M | -1.78M | -2.97M | -2.64M |
Change in Working Capital | -785K | -1.79M | -4.22M | -2.94M | -1.7M | 569K | 4.39M | 2.29M | -1.17M | 2.12M | 5.38M | 9.89M | 11.01M | 6.66M | 35K | -3.71M | -4.05M | -4.96M |
Operating Cash Flow | -22.02M | -23.66M | -25.31M | -23.4M | -21.81M | -21.25M | -19.08M | -23.05M | -27.04M | -20.17M | -16.02M | -15.56M | -10.33M | -15.03M | -19.31M | -15.1M | -16.94M | -17.74M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.98K | 20.98K | -21 | -21 | -21K | -21K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | 4.4M | 4.4M | 4.4M | 4.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | 4.4M | 4.4M | 4.4M | 4.4M | 20.98K | 20.98K | -21 | -21 | -21K | -21K | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 191K | 191K | n/a | -12.5M | -12.6M | -12.6M | -599K | 11.38M | 12.03M | 12.03M | -32K | -79K | n/a | n/a | 172K | -1.01M | -3.23M | -3.23M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 50.1M | 50.14M | 50.14M | n/a | -11.46M | -11.46M | -11.46M | -7.46M | 9.75M | 9.75M | 9.75M | 5.75M | -47K | -47K | n/a | n/a | 47K | 8.33M |
Financial Cash Flow | 2.42M | 2.46M | 52.61M | 52.33M | 50.34M | 50.34M | 12M | 15.95M | 21.78M | 26.82M | 14.75M | 11.35M | 17.38M | 18.72M | 26.98M | 32.84M | 21.39M | 23.28M |
Net Cash Flow | -19.6M | -21.2M | 27.3M | 33.33M | 32.93M | 33.49M | -2.68M | -7.1M | -5.26M | 6.63M | -1.29M | -4.23M | 7.03M | 3.69M | 7.67M | 17.74M | 4.44M | 5.54M |
Free Cash Flow | -22.02M | -23.66M | -25.31M | -23.4M | -21.81M | -21.25M | -19.08M | -23.03M | -27.02M | -20.17M | -16.02M | -15.58M | -10.35M | -15.03M | -19.31M | -15.1M | -16.94M | -17.74M |